Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial
Authors:
Open Access
- 7 January 2015
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 114 (3) , 469-476
Abstract
Intrathecal morphine-induced pruritus is a very common side-effect that is difficult to prevent or treat. Central and peripheral mechanisms are believed to be involved. The aim of this study was to determine if a peripherally acting, μ-opioid antagonist would reduce morphine-induced pruritus. We conducted a multicentre, randomized, blinded, placebo-controlled trial of women having elective Caesarean section under spinal anaesthesia with intrathecal morphine 100 μg. After delivery, participants received either subcutaneous methylnatrexone bromide 12 mg (MNTX group, n=69) or saline (placebo group, n=68). Pruritus, nausea, pain, analgesic use, and side-effects were assessed at 2, 4, 8, and 24 h. The primary outcome was the severity of pruritus (0–10 score). One hundred and thirty-seven women completed the study, with five major protocol violations. There was no statistically significant difference between the MNTX and placebo groups for the median (IQR) pruritus AUC scores [24 (9–47) vs 36 (11–68), median difference 8.5, 95% confidence interval (CI) 0–20, P=0.09] or the worst pruritus score [3 (2–7) vs 5 (2–6), median difference 1, 95% CI 0–2, P=0.24]. The incidence of pruritus was 84% in the MNTX group and 88% in the placebo group (P=0.48). Analgesic and gastrointestinal outcomes did not significantly differ between the groups. A single dose of subcutaneous methylnaltrexone bromide 12 mg did not reduce the overall severity or incidence of pruritus. In this study, treatment with a peripherally acting μ-opioid antagonist was generally ineffective against intrathecal morphine-induced pruritus, but a small clinical effect cannot be excluded. Australian New Zealand Clinical Trials Registry (ACTRN12611000345987).Keywords
This publication has 36 references indexed in Scilit:
- Use of pure opioid antagonists for management of opioid-induced pruritusAmerican Journal of Health-System Pharmacy, 2011
- Intrathecal morphine in anesthesia for cesarean delivery: dose-response relationship for combinations of low-dose intrathecal morphine and spinal bupivacaineJournal of Clinical Anesthesia, 2008
- Subcutaneous naloxone for the prevention of intrathecal morphine induced pruritus in elective Caesarean delivery*Anaesthesia, 2007
- Tolerability, Gut Effects, and Pharmacokinetics of Methylnaltrexone Following Repeated Intravenous Administration in HumansThe Journal of Clinical Pharmacology, 2005
- Activation of κ-Opioid Receptors Inhibits Pruritus Evoked by Subcutaneous or Intrathecal Administration of Morphine in MonkeysThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Itching after intrathecal morphine. Incidence and treatmentEuropean Journal of Anaesthesiology, 2000
- Development and Psychometric Testing of a Quality of Recovery Score After General Anesthesia and Surgery in AdultsAnesthesia & Analgesia, 1999
- Dose-Response Pharmacology of Intrathecal Morphine in Human VolunteersAnesthesiology, 1993
- Intrathecal and Epidural Morphine Sulfate for Postcesarean Analgesia—A Clinical ComparisonAnesthesiology, 1988
- Opiate receptor binding activity of 17-Alpha estrogenic steroidsLife Sciences, 1978